4//SEC Filing
YERXA BENJAMIN R 4
Accession 0001181431-10-026581
CIK 0001040416other
Filed
May 12, 8:00 PM ET
Accepted
May 13, 4:12 PM ET
Size
8.2 KB
Accession
0001181431-10-026581
Insider Transaction Report
Form 4
YERXA BENJAMIN R
EVP & Chf, Research & Develop
Transactions
- Award
Stock Option (Right to Buy)
2010-05-12+17,500→ 17,500 totalExercise: $6.50Exp: 2017-05-11→ Common Stock (17,500 underlying) - Award
Restricted Stock Units
2010-05-12+1,750→ 1,750 total→ Common Stock (1,750 underlying)
Footnotes (3)
- [F1]Shall vest over four (4) years as follows: 25% on the first anniversary of the date of grant, and thereafter in thirty-six (36) monthly installments after the first anniversary date until fully vested.
- [F2]Shall vest as follows: 25% on June 1, 2011; 25% on June 1, 2012; 25% on June 1, 2013 and 25% on June 1, 2014.
- [F3]Each Restricted Stock Unit represents a contingent right to receive one share of the common stock of Inspire Pharmaceuticals, Inc. The shares will be delivered following the end of the scheduled vesting date or 60 days following an earlier vesting date that occurs as a result of the grantee's separation from service.
Documents
Issuer
INSPIRE PHARMACEUTICALS INC
CIK 0001040416
Entity typeother
Related Parties
1- filerCIK 0001145910
Filing Metadata
- Form type
- 4
- Filed
- May 12, 8:00 PM ET
- Accepted
- May 13, 4:12 PM ET
- Size
- 8.2 KB